Perceptive Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $441M | Hold |
|
|||||
|
2024
Q1 | $456M | Sell |
|
|||||
|
2023
Q4 | $465M | Buy |
|
|||||
|
2023
Q3 | $220M | Hold |
|
|||||
|
2023
Q2 | $321M | Buy |
|
|||||
|
2023
Q1 | $159M | Hold |
|
|||||
|
2022
Q4 | $205M | Hold |
|
|||||
|
2022
Q3 | $184M | Buy |
|
|||||
|
2022
Q2 | $134M | Hold |
|
|||||
|
2022
Q1 | $178M | Hold |
|
|||||
|
2021
Q4 | $165M | Hold |
|
|||||
|
2021
Q3 | $150M | Buy |
|
|||||
|
2021
Q2 | $119M | Hold |
|
|||||
|
2021
Q1 | $63.7M | Buy |
|
|||||
|
2020
Q4 | $75.3M | Buy |
|